biotech / news / / Devdiscourse
Q-Line Biotech, a healthcare solutions provider, has raised a little over Rs 61 crore from anchor investors.
Q-Line Biotech raised Rs 61.09 crore from anchor investors at Rs 343 per share.
KEY POINTS
- The IPO is a fresh issue of 62.53 lakh equity shares with face value Rs 10 each.
- IPO proceeds will fund working capital, debt repayment, and general corporate purposes.
- Q-Line Biotech reported Rs 232.42 crore revenue and Rs 38.7 crore PAT for nine months ending December 2025.
- Shares are set to list on NSE SME Emerge with a tentative listing date of May 29, 2026.
COMPANIES
Summarized by Newsio from Devdiscourse. How we summarize →